BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38040321)

  • 21. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
    Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
    JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.
    Kooi IE; Mol BM; Massink MP; de Jong MC; de Graaf P; van der Valk P; Meijers-Heijboer H; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    PLoS One; 2016; 11(4):e0153323. PubMed ID: 27115612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers.
    Le Gall J; Dehainault C; Benoist C; Matet A; Lumbroso-Le Rouic L; Aerts I; Jiménez I; Schleiermacher G; Houdayer C; Radvanyi F; Frouin E; Renault V; Doz F; Stoppa-Lyonnet D; Gauthier-Villars M; Cassoux N; Golmard L
    J Mol Diagn; 2021 Dec; 23(12):1714-1721. PubMed ID: 34656762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma.
    Luo Y; Xu M; Yang L; Yao Y; Berry JL; Xu L; Wen X; He X; Han M; Fan X; Fan J; Jia R
    Br J Ophthalmol; 2024 Feb; 108(3):449-456. PubMed ID: 36931696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
    Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
    Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
    Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
    J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational screening of germline
    Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
    Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management.
    Soliman SE; VandenHoven C; MacKeen LD; Héon E; Gallie BL
    Ophthalmology; 2017 Jun; 124(6):859-872. PubMed ID: 28318638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal versus Postnatal Screening for Familial Retinoblastoma.
    Soliman SE; Dimaras H; Khetan V; Gardiner JA; Chan HS; Héon E; Gallie BL
    Ophthalmology; 2016 Dec; 123(12):2610-2617. PubMed ID: 27712844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).
    Kugalingam N; De Silva D; Abeysekera H; Nanayakkara S; Tirimanne S; Ranaweera D; Suravajhala P; Chandrasekharan V
    BMC Med Genomics; 2023 Nov; 16(1):279. PubMed ID: 37932687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy.
    Li HT; Xu L; Weisenberger DJ; Li M; Zhou W; Peng CC; Stachelek K; Cobrinik D; Liang G; Berry JL
    Nat Commun; 2022 Sep; 13(1):5523. PubMed ID: 36130950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of mutations in the
    Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
    Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Same Mutation, Earlier Detection.
    Yaghy A; Eiger-Moscovich M; Shields CL
    Ophthalmol Retina; 2020 Apr; 4(4):402. PubMed ID: 32273112
    [No Abstract]   [Full Text] [Related]  

  • 36. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
    Singh J; Mishra A; Pandian AJ; Mallipatna AC; Khetan V; Sripriya S; Kapoor S; Agarwal S; Sankaran S; Katragadda S; Veeramachaneni V; Hariharan R; Subramanian K; Mannan AU
    Mol Vis; 2016; 22():1036-47. PubMed ID: 27582626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROUTINE FUNDUS SCREENING OF FAMILIES OF CHILDREN WITH RETINOBLASTOMA: A Prospective Study of 131 Consecutive Families.
    Kaliki S; Gupta Rathi S; Patel A
    Retina; 2019 Jul; 39(7):1326-1332. PubMed ID: 29470311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex ligation-dependent probe amplification versus fluorescent in situ hybridization for screening
    Eid OM; El Zomor H; Mohamed AM; El-Bassyouni HT; Afifi HH; El-Ayadi M; Sadek SH; Hammad SA; Salem SI; Mahrous R; Fadel IM; Refaat K; Afifi MA; Shelil AE; Ziko OAO; Abdel Azeem AA; El-Haddad A
    Ophthalmic Genet; 2022 Dec; 43(6):789-794. PubMed ID: 36098066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multicenter Analysis of Nucleic Acid Quantification Using Aqueous Humor Liquid Biopsy in Retinoblastoma: Implications for Clinical Testing.
    Im DH; Pike S; Reid MW; Peng CC; Sirivolu S; Grossniklaus HE; Hubbard GB; Skalet AH; Bellsmith KN; Shields CL; Lally SE; Stacey AW; Reiser BJ; Nagiel A; Shah R; Xu L; Berry JL
    Ophthalmol Sci; 2023 Sep; 3(3):100289. PubMed ID: 37025945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic).
    Reddy MA; Butt M; Hinds AM; Duncan C; Price EA; Sagoo MS; Onadim Z
    Ophthalmol Retina; 2021 Apr; 5(4):381-387. PubMed ID: 32835838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.